104 related articles for article (PubMed ID: 9561329)
1. Factor XIIIa-immunoreactivity in tumors of the central nervous system.
Probst-Cousin S; Rickert CH; Gullotta F
Clin Neuropathol; 1998; 17(2):79-84. PubMed ID: 9561329
[TBL] [Abstract][Full Text] [Related]
2. Fas (Apo-1, CD95) receptor expression in childhood astrocytomas. Is it a marker of the major apoptotic pathway or a signaling receptor for immune escape of neoplastic cells?
Bodey B; Bodey B; Siegel SE; Kaiser HE
In Vivo; 1999; 13(4):357-73. PubMed ID: 10586378
[TBL] [Abstract][Full Text] [Related]
3. Factor XIIIa immunoreactivity in primary and secondary tumours of the meninges.
Gottschalk J; Jautzke G; Märzheuser-Brands S; Cervos-Navarro J
Zentralbl Pathol; 1993 Nov; 139(4-5):343-9. PubMed ID: 7907501
[TBL] [Abstract][Full Text] [Related]
4. Mitogenic lectin receptors of nervous system tumors. Study of gliomas, neural crest tumors, and meningiomas in vitro using phytohemagglutinin and concanavalin A.
Liwnicz BH
J Neuropathol Exp Neurol; 1982 May; 41(3):281-97. PubMed ID: 6281395
[TBL] [Abstract][Full Text] [Related]
5. Expression of survivin, an inhibitor of apoptosis protein, in tumors of the nervous system.
Sasaki T; Lopes MB; Hankins GR; Helm GA
Acta Neuropathol; 2002 Jul; 104(1):105-9. PubMed ID: 12070671
[TBL] [Abstract][Full Text] [Related]
6. A clinicopathological and immunohistochemical study of central nervous system hemangiopericytomas.
Sundaram C; Uppin SG; Uppin MS; Rekha JS; Panigrahi MK; Purohit AK; Rammurti S
J Clin Neurosci; 2010 Apr; 17(4):469-72. PubMed ID: 20167500
[TBL] [Abstract][Full Text] [Related]
7. Anaplastic meningioma versus meningeal hemangiopericytoma: immunohistochemical and genetic markers.
Rajaram V; Brat DJ; Perry A
Hum Pathol; 2004 Nov; 35(11):1413-8. PubMed ID: 15668900
[TBL] [Abstract][Full Text] [Related]
8. Spreading and migration of human glioma and rat C6 cells on central nervous system myelin in vitro is correlated with tumor malignancy and involves a metalloproteolytic activity.
Amberger VR; Hensel T; Ogata N; Schwab ME
Cancer Res; 1998 Jan; 58(1):149-58. PubMed ID: 9426071
[TBL] [Abstract][Full Text] [Related]
9. Determination of RNA expression for cholecystokinin/gastrin receptors (CCKA, CCKB and CCKC) in human tumors of the central and peripheral nervous system.
Lefranc F; Chaboteaux C; Belot N; Brotchi J; Salmon I; Kiss R
Int J Oncol; 2003 Jan; 22(1):213-9. PubMed ID: 12469207
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical expression of SPARC is correlated with recurrence, survival and malignant potential in meningiomas.
Bozkurt SU; Ayan E; Bolukbasi F; Elmaci I; Pamir N; Sav A
APMIS; 2009 Sep; 117(9):651-9. PubMed ID: 19703125
[TBL] [Abstract][Full Text] [Related]
11. Central nervous system.
Adamson DC; Rasheed BA; McLendon RE; Bigner DD
Cancer Biomark; 2010; 9(1-6):193-210. PubMed ID: 22112477
[TBL] [Abstract][Full Text] [Related]
12. A sequential scanning of the immune efficiency in astrocytoma (Grade I to Grade Iii), meningioma and secondary glioma patients with and without therapeutic scheduling.
Bhattacharjee M; Bose I; Sarkar P; Banerjee C; Dutta S; Ghosh A; Mukherjee J; Acharya S; Goswami S; Mazumdar A; Chaudhuri S; Chaudhuri S
Cancer Invest; 2006; 24(5):502-13. PubMed ID: 16939959
[TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical staining for claudin-1 can help distinguish meningiomas from histologic mimics.
Hahn HP; Bundock EA; Hornick JL
Am J Clin Pathol; 2006 Feb; 125(2):203-8. PubMed ID: 16393681
[TBL] [Abstract][Full Text] [Related]
14. Microtubule-associated protein-2 immunoreactivity: a useful tool in the differential diagnosis of low-grade neuroepithelial tumors.
Blümcke I; Müller S; Buslei R; Riederer BM; Wiestler OD
Acta Neuropathol; 2004 Aug; 108(2):89-96. PubMed ID: 15146346
[TBL] [Abstract][Full Text] [Related]
15. Melanoma-inhibiting activity (MIA/CD-RAP) is expressed in a variety of malignant tumors of mainly neuroectodermal origin.
Hau P; Apfel R; Wiese P; Tschertner I; Blesch A; Bogdahn U
Anticancer Res; 2002; 22(2A):577-83. PubMed ID: 12014625
[TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical expression of PTTG in brain tumors.
Salehi F; Scheithauer BW; Sharma S; Kovacs K; Lloyd RV; Cusimano MD; Munoz DG
Anticancer Res; 2013 Jan; 33(1):119-22. PubMed ID: 23267136
[TBL] [Abstract][Full Text] [Related]
17. Expression of doublecortin in tumours of the central and peripheral nervous system and in human non-neuronal tissues.
Bernreuther C; Salein N; Matschke J; Hagel C
Acta Neuropathol; 2006 Mar; 111(3):247-54. PubMed ID: 16520969
[TBL] [Abstract][Full Text] [Related]
18. Vascular endothelial growth factor mRNA expression and peritumoral edema in canine primary central nervous system tumors.
Dickinson PJ; Sturges BK; Higgins RJ; Roberts BN; Leutenegger CM; Bollen AW; LeCouteur RA
Vet Pathol; 2008 Mar; 45(2):131-9. PubMed ID: 18424825
[TBL] [Abstract][Full Text] [Related]
19. Increased expression of podoplanin in malignant astrocytic tumors as a novel molecular marker of malignant progression.
Mishima K; Kato Y; Kaneko MK; Nishikawa R; Hirose T; Matsutani M
Acta Neuropathol; 2006 May; 111(5):483-8. PubMed ID: 16596424
[TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical detection of p53 protein in tumours of the central nervous system.
Kuchelmeister K; Elborg B; Gullotta F
Pathologica; 1995 Oct; 87(5):498-502. PubMed ID: 8868174
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
